OBCI · Ocean Bio Chem Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $15.21M | $12.74M | - | $21.48M | $15.69M | $13.13M | - | $19.16M | $15.70M | $7.82M |
| Cost of Revenue | $9.86M | $8.00M | - | $14.03M | $8.42M | $7.75M | - | $10.41M | $7.99M | $4.68M |
| Gross Profit | $5.35M | $4.74M | - | $7.45M | $7.27M | $5.38M | - | $8.75M | $7.71M | $3.14M |
| R&D | - | - | - | - | - | $12.0K | - | - | - | - |
| SG&A | $4.05M | $2.00M | - | $2.29M | $2.64M | $1.97M | - | $2.03M | $2.50M | $1.71M |
| Total Operating Expenses | $5.68M | $3.07M | - | $3.25M | $3.91M | $2.91M | - | $2.75M | $3.30M | $2.45M |
| D&A | $385.0K | $328.9K | - | $302.9K | $292.8K | $254.3K | - | - | - | - |
| Operating Income | ($329.4K) | $1.66M | - | $4.21M | $3.37M | $2.47M | - | $5.99M | $4.40M | $691.2K |
| Interest Expense | $79.1K | $31.7K | - | $35.8K | $40.8K | $37.2K | - | $39.6K | $38.2K | $15.9K |
| Income Tax | ($87.1K) | $333.4K | - | $899.7K | $723.1K | $524.6K | - | $1.30M | $914.1K | $174.6K |
| Net Income | ($321.4K) | $1.30M | - | $3.27M | $2.60M | $1.90M | - | $4.66M | $3.45M | $626.9K |
| EPS - Basic | ($0.03) | $0.14 | - | $0.34 | $0.27 | $0.20 | - | $0.49 | $0.37 | $0.07 |
| EPS - Diluted | - | - | - | $0.34 | $0.27 | $0.20 | - | $0.49 | $0.36 | $0.07 |
Balance Sheet
| Line item | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7.02M | $10.22M | $12.68M | $10.68M | $8.30M | $11.16M | $11.12M | $6.58M | $4.68M | $6.15M |
| Accounts Receivable | $11.58M | $10.26M | $9.54M | $17.23M | $12.66M | $10.35M | $8.33M | $16.26M | $12.84M | $6.40M |
| Inventory | $23.58M | $19.97M | $16.82M | $16.79M | $16.74M | $14.23M | $13.18M | $12.32M | $11.68M | $11.36M |
| Accounts Payable | $3.74M | $3.38M | $2.88M | $5.08M | $4.29M | $3.14M | $1.97M | $3.76M | $2.29M | $2.00M |
| Current Assets | $45.40M | $42.89M | $42.35M | $47.29M | $40.13M | $38.62M | $35.86M | $37.99M | $32.88M | $28.00M |
| Total Assets | $65.09M | $62.00M | $60.28M | $63.13M | $54.33M | $51.20M | $47.90M | $50.11M | $45.04M | $39.81M |
| Current Liabilities | $9.59M | $5.54M | $4.65M | $7.73M | $6.44M | $5.61M | $3.70M | $6.71M | $6.00M | $3.84M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $17.37M | $13.58M | $12.84M | $16.24M | $10.43M | $9.67M | $7.99M | $11.17M | $10.56M | $8.45M |
| Stockholders' Equity | $47.72M | $48.42M | $47.44M | $46.89M | $43.90M | $41.53M | $39.91M | $38.94M | $34.48M | $31.36M |
| Retained Earnings | $36.77M | $37.47M | $36.56M | $36.21M | $33.23M | $30.91M | $29.29M | $28.60M | $24.13M | $21.06M |
Cash Flow
| Line item | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | ($238.8K) | - | - | - | $1.21M | - | - | - | $287.8K |
| Investing Cash Flow | - | ($1.61M) | - | - | - | ($915.9K) | - | - | - | ($129.4K) |
| Financing Cash Flow | - | ($619.1K) | - | - | - | ($414.5K) | - | - | - | ($126.7K) |
| CapEx | - | $1.61M | - | - | - | $915.9K | - | - | - | $541.1K |
| Free Cash Flow | - | ($1.85M) | - | - | - | $291.9K | - | - | - | ($253.3K) |
Ratios
| Metric | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 35.2% | 37.2% | - | 34.7% | 46.4% | 41.0% | - | 45.7% | 49.1% | 40.2% |
| Operating margin | -2.2% | 13.1% | - | 19.6% | 21.4% | 18.8% | - | 31.3% | 28.1% | 8.8% |
| EBITDA margin | 0.4% | 15.6% | - | 21.0% | 23.3% | 20.7% | - | - | - | - |
| Net margin | -2.1% | 10.2% | - | 15.2% | 16.6% | 14.5% | - | 24.3% | 22.0% | 8.0% |
| Free cash flow margin | - | -14.5% | - | - | - | 2.2% | - | - | - | -3.2% |
| FCF / Net income | - | -1.42 | - | - | - | 0.15 | - | - | - | -0.40 |
| R&D / Revenue | - | - | - | - | - | 0.1% | - | - | - | - |
| SG&A / Revenue | 26.6% | 15.7% | - | 10.7% | 16.8% | 15.0% | - | 10.6% | 15.9% | 21.9% |
| Effective tax rate | - | 20.4% | - | 21.6% | 21.8% | 21.6% | - | 21.8% | 20.9% | 21.8% |
| Return on assets | -0.5% | 2.1% | - | 5.2% | 4.8% | 3.7% | - | 9.3% | 7.7% | 1.6% |
| Return on equity | -0.7% | 2.7% | - | 7.0% | 5.9% | 4.6% | - | 12.0% | 10.0% | 2.0% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 4.73 | 7.74 | 9.11 | 6.12 | 6.23 | 6.89 | 9.70 | 5.66 | 5.48 | 7.29 |
| Quick ratio | 2.27 | 4.14 | 5.49 | 3.95 | 3.63 | 4.35 | 6.14 | 3.83 | 3.53 | 4.33 |
| Cash ratio | 0.73 | 1.84 | 2.73 | 1.38 | 1.29 | 1.99 | 3.01 | 0.98 | 0.78 | 1.60 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -4.2x | 52.5x | - | 117.6x | 82.4x | 66.3x | - | 151.3x | 115.3x | 43.5x |
| Equity multiplier | 1.36 | 1.28 | 1.27 | 1.35 | 1.24 | 1.23 | 1.20 | 1.29 | 1.31 | 1.27 |
| Liabilities / Assets | 0.27 | 0.22 | 0.21 | 0.26 | 0.19 | 0.19 | 0.17 | 0.22 | 0.23 | 0.21 |
| Efficiency | ||||||||||
| Asset turnover | 0.23 | 0.21 | - | 0.34 | 0.29 | 0.26 | - | 0.38 | 0.35 | 0.20 |
| Inventory turnover | 0.42 | 0.40 | - | 0.84 | 0.50 | 0.54 | - | 0.85 | 0.68 | 0.41 |
| Days sales outstanding | 278d | 294d | - | 293d | 294d | 288d | - | 310d | 298d | 299d |
| Days inventory outstanding | 873d | 911d | - | 437d | 726d | 670d | - | 432d | 533d | 887d |
| Days payable outstanding | 138d | 154d | - | 132d | 186d | 148d | - | 132d | 105d | 156d |
| Cash conversion cycle | 1013d | 1051d | - | 597d | 834d | 810d | - | 610d | 727d | 1030d |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -3.1% | -3.0% | - | 12.1% | -0.1% | 67.9% | - | 53.3% | 43.5% | -13.9% |
| Revenue CAGR (3y) | 11.6% | 11.9% | - | 17.7% | 11.2% | 16.1% | - | 18.0% | 16.6% | -2.3% |
| Revenue CAGR (5y) | 9.0% | 8.7% | - | 12.0% | 12.5% | 14.2% | - | 12.1% | 12.4% | 5.4% |
| Gross profit growth (YoY) | -26.4% | -12.0% | - | -14.8% | -5.6% | 71.2% | - | 98.5% | 70.6% | -8.1% |
| Operating income growth (YoY) | - | -32.5% | - | -29.8% | -23.6% | 256.8% | - | 306.4% | 231.3% | -27.6% |
| Net income growth (YoY) | - | -31.8% | - | -29.8% | -24.7% | 203.8% | - | 314.1% | 242.0% | -12.3% |
| EPS growth (YoY) | - | - | - | -30.6% | -25.0% | 185.7% | - | 308.3% | 227.3% | -12.5% |
| EPS CAGR (3y) | - | - | - | 34.4% | 31.0% | 49.4% | - | 75.9% | 53.3% | - |
| EPS CAGR (5y) | - | - | - | 14.9% | 31.0% | - | - | 74.8% | 104.8% | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | 72.2% |
| FCF CAGR (5y) | - | - | - | - | - | 36.6% | - | - | - | - |
| Book value growth (YoY) | 8.7% | 16.6% | 18.9% | 20.4% | 27.3% | 32.4% | 29.8% | 29.4% | 20.0% | 13.2% |
Peer comparison
Same SIC group: Specialty Cleaning, Polishing and Sanitation Preparations
Comparing OCEAN BIO CHEM INC against the 4 most active filers in the same SIC group.